Search results
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Clinical Trials Arena via Yahoo Finance· 4 hours agoAstraZeneca has announced that the Phase III SUPERNOVA clinical trial of its sipavibart (formerly...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 21 hours ago(Photo Illustration by Jakub Porzycki/NurPhoto/Getty Images) Since last week, hundreds of social...
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity,...
Benzinga via Yahoo Finance· 19 hours agoThursday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the SUPERNOVA Phase 3...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 22 hours agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patients
Reuters via AOL· 1 day agoThe long-acting antibody therapy called sipavibart showed a "statistically significant reduction" in...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company ...
Vaccine trial patient files first US lawsuit against AstraZeneca
The Telegraph via Yahoo News· 4 days agoAn American woman who took part in the US clinical trial of the AstraZeneca Covid vaccine is suing...
AstraZeneca's COVID prevention drug meets primary goals in late-stage study
Reuters· 1 day agoAstraZeneca's investigational COVID-19 prevention therapy met its primary goals in a late-stage...
Equities Analysts Offer Predictions for AstraZeneca PLC’s Q2 2024 Earnings (NASDAQ:AZN)
ETF DAILY NEWS· 1 day agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Research analysts at Zacks Research reduced their Q2 2024 earnings per share estimates for AstraZeneca in a ...
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success
FierceBiotech· 1 day agoWhile AstraZeneca’s globally used COVID-19 vaccine is leaving the scene, the British Big Pharma is...